13 years 🥳 of Publication, 100k+ Stories, 30+ Countries
Search
The Latest News from All Areas of Deals
Latham & Watkins Advises on Artiva Biotherapeutics’ US$167 Million Initial Public Offering
Firm represents the underwriters in the IPO by the clinical-stage biotechnology company. Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology…
Latham & Watkins Advises Invetx in Acquisition by Dechra Pharmaceuticals
Multidisciplinary team represents the pioneer in protein-based therapeutics for animal health in the transaction. Invetx, Inc., a pioneer in protein-based…
Latham Advises on Infrastructure Financing of Quartz Healthcare
Latham & Watkins has advised the banks and the institutional infrastructure investors on the financing of Quartz Healthcare, a portfolio…
Latham Advises Health Catalyst in Secured Growth Financing
Firm represented the leading provider of healthcare data technology in a new growth financing. Health Catalyst, Inc. (Nasdaq: HCAT) (Health…
Latham & Watkins Advises on the Update of Saudi Aramco’s GMTN Program and US$6 Billion Notes Issuance
Multi-jurisdictional team supports oil giant in its return to the debt market. Latham & Watkins has advised the arrangers and…
Linklaters advises Keolis on the signing of an agreement for the acquisition of passenger transport activities in Canada
Linklaters advises Keolis on the signing of an agreement with Student Transportation of America (STA) for the acquisition of the…
